Compare AdaptHealth Corp (AHCO) vs Eni SpA (E) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Eni SpA — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Eni SpA trades at $48.36 (market cap $67.72B). The key difference: Eni SpA is far larger — about 49.1× AdaptHealth Corp's market cap, and Eni SpA pays a 5.25% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | E | |
|---|---|---|
Market Cap | $1.38B | $67.72B |
Sector | Health | Energy |
52-Week High | $13.38 | $57.61 |
52-Week Low | $8.68 | $32.93 |
Enterprise Value | $3.33B | $86.63B |
Dividend Yield | — | 5.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Eni (E) trades at $47.47, up 1.28% with a bearish technical signal despite recent earnings beats. The company shows stable cash flow generation with $13.33B operating cash flow in 2025 and maintains a reasonable valuation with P/E of 20.51 and P/S of 0.75. Recent strategic moves include lithium investments in Chile and fusion energy partnerships, signaling diversification beyond traditional energy operations.
While analyst consensus leans neutral (61.53% hold), Eni's transition strategy and global expansion present long-term opportunities. Key risks include declining revenue trends from $132.5B in 2022 to $82.15B in 2025 and competitive pressures in the energy sector. The stock offers value characteristics with dividend income potential amid ongoing business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Eni SpA
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2021, Eni held reserves of 6.6 billion barrels of oil equivalent, 49% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity, Plentitude
Read more on E →
